Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Ischemic Stroke due to Postmenopausal Hormone Therapy

Author(s):
Rossouw, J.E.; Johnson, K.C.; Pettinger, M.; Cushman, M.; Sandset, P.M.; Kuller, L.; Rosendaal, F.; Rosing, J.; Wasserthal-Smoller, S.; Martin, L.W.; Manson, J.E.; Lakshminarayan, K.; Merino, J.G.; Lynch, J.
Published
2012
Publication type
Article / Letter to editor
cerebrovascular accidentestrogenhemostasismenopauserandomized controlled trials
Date issued
2012-04-30
Language
English
Is part of
Stroke (2012), Vol. 43, no. 4, p. 952-957
hdl
1887/118407
doi
10.1161/STROKEAHA.111.643072